Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Placebo-controlled, Randomized Study of Oral Immunomodulator in TB and TB/HIV Patients

NCT01222338 is registered in ClinicalTrials.gov with Lisichansk Regional Tuberculosis Dispensary as lead sponsor.

NCT NCT01222338
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01222338 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Placebo-controlled, Randomized Study of Oral Immunomodulator in TB and TB/HIV Patients
Lead sponsor
Lisichansk Regional Tuberculosis Dispensary
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2010
Completion date
January 31, 2011
Enrollment
123 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis